AMCP 2011
COMING SOON...
Coverage from the Academy of Managed Care Pharmacy’s 23rd Annual Meeting & Showcase. Our reporting from the conference will include video interviews with thought leaders and coverage of special healthcare reform implementation issues, payment reform, care delivery, coverage requirements, comparative effectiveness research, and more.
 
Don’t miss our as-they-happen highlights from the nation’s premier event regarding managed care pharmacy.
More on AJMC.COM
Health Reform Plans, Pricing Revealed in Calif.
Dr. Jeff Goldsmith Addresses the Unintended Consequences of ACOs
Jeff Goldsmith, PhD, President, Health Futures, Inc, Associate Professor of Public Health Sciences, University of Virginia, says that the biggest barrier that accountable care organizations (ACOs) face is the lack of collaboration between physician communities and hospitals.
Forget to Take Medicine? These Pills Will Tell Your Doctor
NOW AVAILABLE: AMCP Spring 2013 Conference Coverage
Highlights from The Academy of Managed Care Pharmacy's 25th Meeting & Expo, which took place on April 2–5, 2013, in San Diego, CA, are available in a newsletter published by The American Journal of Managed Care.
The Affordable Care Act: Implications for Clinical Practice and Research
In "What Does the Affordable Care Act Actually Do?," presented by Ivor Douglas, MD, Associate Professor, University of Colorado Denver, Chief, Pulmonary Sciences and Critical Care Medicine Director, Medical Intensive Care, Denver Health Medical Center, at the ATS 2013 International Conference, Dr Douglas noted that fundamental issues driving the Affordable Care Act (ACA) include access, quality, and cost.
Dr Richard Channick, MD, Discusses Clinical Trial in Pulmonary Hypertension
Richard Channick, MD, Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital, Boston, MA, spoke at the 2013 American Thoracic Society International Conference as part of a session featuring the Clinical Trials in Pulmonary Hypertension.
Dr. Richard Channick Addresses a New Treatment in Pulmonary Arterial Hypertension
In this video, Richard Channick, MD, Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital, Boston, MA, speaks about the use of Macitentan for the treatment of pulmonary arterial hypertension (PAH).
About Us | Contact Us | Advertise | Terms & Conditions | Press Room | Copyright HCPLive 2006-2013 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive